Bristol-Myers Squibb Co.
| Държава: | ----- |
| Кратка информация: | We take our company's mission seriously: to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. At Bristol-Myers Squibb, we’re on the leading edge of science and technology to discover and develop new medicines. We measure our success by the difference we can make in the lives of patients, offering them new treatment options and, more importantly, new hope. Since 2002, our R&D team has helped to bring to market 11 key medicines to treat cancer, schizophrenia, depression, HIV/AIDS, hepatitis B, rheumatoid arthritis and diabetes. Three of these medicines are biologics. In the fight against serious disease, biologics are playing an increasingly prominent role. More than one-third of our compounds in development are biologics. Our pipeline continues to expand. In 2010, 15 new compounds entered preclinical development, and six transitioned to mid-stage clinical testing. In addition, we had a record number of new product submissions. Our vision as a BioPharma leader is to combine the best elements of a traditional pharmaceutical company and those of a leading-edge biotech company by focusing on innovation, selective integration and continuous improvement. Our R&D strategy is to pursue significant areas of unmet medical need by leveraging our legacy in discovering and developing high-potency small molecules as well as our growing experience and expertise in highly targeted biologics. Building on the past, accelerating to the future. It’s all part of being BioPharma. |
| Сайт: | http://www.bms.com/pages/default.aspx |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
